TP53 and neoplasm: The DEGs of HLM regulators in TCGA-PRAD data stratified by CNV loss or gain (CNV), tumor vs. normal (TN), GS > 7 vs. GS < 7 (GS), pT3 vs. pT2 (pT), TP53 mutation vs. wild type (TP53), and RFS high vs. low expression were analyzed, and the intersecting genes were validated using clinical PCa tissues.